Gumersindo Abellán

Antiobesity effects of the novel in vivo neutral cannabinoid receptor antagonist 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole – LH 21

F. Pavón, A. Serrano, A. Cippitelli, 2006, Neuropharmacology.